Integrated BioPharma, Inc. (INBP)
OTCMKTS
· Delayed Price · Currency is USD
0.2810
0.00 (0.00%)
Jun 3, 2025, 10:14 AM EDT
Integrated BioPharma Revenue
Integrated BioPharma had revenue of $13.95M in the quarter ending March 31, 2025, with 6.09% growth. This brings the company's revenue in the last twelve months to $52.92M, up 4.67% year-over-year. In the fiscal year ending June 30, 2024, Integrated BioPharma had annual revenue of $50.32M, down -0.70%.
Revenue (ttm)
52.92M
Revenue Growth
+4.67%
P/S Ratio
0.16
Revenue / Employee
360.03K
Employees
147
Market Cap
8.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 50.32M | -355.00K | -0.70% |
| Jun 30, 2023 | 50.67M | -5.57M | -9.91% |
| Jun 30, 2022 | 56.25M | -7.31M | -11.51% |
| Jun 30, 2021 | 63.56M | 10.79M | 20.45% |
| Jun 30, 2020 | 52.77M | 2.79M | 5.59% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cordyceps Sunshine Biotech Holdings | 882.53K |
| Cuisine Solutions | 80.48M |
| Armanino Foods of Distinction | 69.40M |
| South Dakota Soybean Processors, LLC | 524.07M |
| ESG Inc. | 11.89M |
| Pyxus International | 2.38B |
| Crimson Wine Group | 71.52M |
| Hongchang International | 2.87M |
Integrated BioPharma News
- 19 days ago - Integrated BioPharma GAAP EPS of $0.02, revenue of $13.9M - Seeking Alpha
- 20 days ago - Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 - Accesswire
- 3 months ago - Integrated BioPharma GAAP EPS of $0.00, revenue of $12.6M - Seeking Alpha
- 3 months ago - Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 - Accesswire
- 7 months ago - Integrated BioPharma GAAP EPS of $0.01, revenue of $13.6M - Seeking Alpha
- 7 months ago - Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 - Accesswire
- 9 months ago - Integrated BioPharma reports Q4 results - Seeking Alpha
- 9 months ago - Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 - Accesswire